These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 1320666
1. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yaşargil MG, Wiestler OD. J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666 [Abstract] [Full Text] [Related]
2. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF, Miller DC, Koslow M, Newcomb EW. J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [Abstract] [Full Text] [Related]
3. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme. Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, Benito R, Roldan P, Piquer J, Llacer J, Barbera J. Clin Neuropathol; 2005 Sep; 24(5):209-18. PubMed ID: 16167544 [Abstract] [Full Text] [Related]
4. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG. Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308 [Abstract] [Full Text] [Related]
5. Somatic mutations of PTEN in glioblastoma multiforme. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Cancer Res; 1997 Oct 01; 57(19):4183-6. PubMed ID: 9331071 [Abstract] [Full Text] [Related]
7. Subsets of glioblastoma multiforme defined by molecular genetic analysis. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Brain Pathol; 1993 Jan 01; 3(1):19-26. PubMed ID: 8269081 [Abstract] [Full Text] [Related]
8. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas. Jin W, Xu X, Yang T, Hua Z. Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043 [Abstract] [Full Text] [Related]
9. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. Yadav AK, Renfrow JJ, Scholtens DM, Xie H, Duran GE, Bredel C, Vogel H, Chandler JP, Chakravarti A, Robe PA, Das S, Scheck AC, Kessler JA, Soares MB, Sikic BI, Harsh GR, Bredel M. JAMA; 2009 Jul 15; 302(3):276-89. PubMed ID: 19602687 [Abstract] [Full Text] [Related]
10. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G. Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190 [Abstract] [Full Text] [Related]
11. Loss of constitutional heterozygosity in human astrocytomas. Van de Kelft E, De Boulle K, Willems P, Martin JJ, Selosse P, Van der Auwera B. Acta Neurochir (Wien); 1992 May 01; 117(3-4):172-7. PubMed ID: 1357919 [Abstract] [Full Text] [Related]
12. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB. J Natl Cancer Inst; 2001 Aug 15; 93(16):1246-56. PubMed ID: 11504770 [Abstract] [Full Text] [Related]
13. Molecular pathogenesis of pediatric astrocytic tumors. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N. Neuro Oncol; 2007 Apr 15; 9(2):113-23. PubMed ID: 17327574 [Abstract] [Full Text] [Related]
14. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Wullich B, Sattler HP, Fischer U, Meese E. Anticancer Res; 1994 Apr 15; 14(2A):577-9. PubMed ID: 8017863 [Abstract] [Full Text] [Related]
16. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T. Clin Cancer Res; 2002 Jan 15; 8(1):196-201. PubMed ID: 11801559 [Abstract] [Full Text] [Related]
17. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C. Neuropathology; 2010 Aug 15; 30(4):392-400. PubMed ID: 20051017 [Abstract] [Full Text] [Related]
19. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255 [Abstract] [Full Text] [Related]
20. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Aghi M, Gaviani P, Henson JW, Batchelor TT, Louis DN, Barker FG. Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8600-5. PubMed ID: 16361543 [Abstract] [Full Text] [Related] Page: [Next] [New Search]